These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 7856280)

  • 1. [Cardioprotective effects by ramipril after ischemia and reperfusion in animal experiment studies].
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Z Kardiol; 1994; 83 Suppl 4():53-6. PubMed ID: 7856280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Local inhibition of bradykinin degradation in ischemic hearts.
    Linz W; Martorana PA; Schölkens BA
    J Cardiovasc Pharmacol; 1990; 15 Suppl 6():S99-109. PubMed ID: 1697370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of kinins to the cardiovascular actions of angiotensin-converting enzyme inhibitors.
    Linz W; Wiemer G; Gohlke P; Unger T; Schölkens BA
    Pharmacol Rev; 1995 Mar; 47(1):25-49. PubMed ID: 7784479
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [ACE inhibition: mechanisms of "cardioprotection" in acute myocardial ischemia].
    Schölkens BA; Linz W
    Klin Wochenschr; 1991; 69 Suppl 24():1-5. PubMed ID: 1865630
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardioprotective actions of bradykinin in myocardial ischemia and left ventricular hypertrophy.
    Linz W; Wiemer G; Schölkens BA
    Braz J Med Biol Res; 1994 Aug; 27(8):1949-54. PubMed ID: 7749386
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of kinins in the pathophysiology of myocardial ischemia. In vitro and in vivo studies.
    Linz W; Wiemer G; Schölkens BA
    Diabetes; 1996 Jan; 45 Suppl 1():S51-8. PubMed ID: 8529801
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of bradykinin in the cardiac effects of angiotensin-converting enzyme inhibitors.
    Linz W; Schölkens BA
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S83-90. PubMed ID: 1282635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of endothelium-derived bradykinin in the control of vascular tone.
    Hecker M; Dambacher T; Busse R
    J Cardiovasc Pharmacol; 1992; 20 Suppl 9():S55-61. PubMed ID: 1282631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental evidence for effects of ramipril on cardiac and vascular hypertrophy beyond blood pressure reduction.
    Linz W; Gohlke P; Unger T; Schölkens BA
    Arch Mal Coeur Vaiss; 1995 Feb; 88 Spec No 2():31-4. PubMed ID: 7646309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Contribution of bradykinin to the cardiovascular effects of ramipril.
    Linz W; Wiemer G; Schölkens BA
    J Cardiovasc Pharmacol; 1993; 22 Suppl 9():S1-8. PubMed ID: 7514234
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardioprotective effects of ACE inhibitors: experimental proof and clinical perspectives.
    Schölkens BA; Linz W
    Clin Physiol Biochem; 1990; 8 Suppl 1():33-43. PubMed ID: 2147878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ramipril improves nitric oxide availability in hypertensive rats with failing hearts after myocardial infarction.
    Linz W; Itter G; Dobrucki LW; Malinski T; Wiemer G
    J Renin Angiotensin Aldosterone Syst; 2003 Sep; 4(3):180-5. PubMed ID: 14608524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Influence of the thromboxane synthetase inhibitor HOE 944, prostacyclin and indomethacin on reperfusion arrhythmias, cardiodynamics and metabolism in isolated ischemic rat hearts.
    Linz W; Lau HH; Beck G; Schökens BA
    Biomed Biochim Acta; 1988; 47(10-11):S23-6. PubMed ID: 3073762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ramipril-induced delayed myocardial protection against free radical injury involves bradykinin B2 receptor-NO pathway and protein synthesis.
    Jin ZQ; Chen X
    Br J Pharmacol; 1998 Oct; 125(3):556-62. PubMed ID: 9806340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective modulation of endogenous nitric oxide formation in ischemia/reperfusion injury in isolated rat hearts--effects on regional myocardial flow and enzyme release.
    Han H; Kaiser R; Hu K; Laser M; Ertl G; Bauersachs J
    Basic Res Cardiol; 2003 May; 98(3):165-74. PubMed ID: 12883834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ACE-inhibition induces NO-formation in cultured bovine endothelial cells and protects isolated ischemic rat hearts.
    Linz W; Wiemer G; Schölkens BA
    J Mol Cell Cardiol; 1992 Aug; 24(8):909-19. PubMed ID: 1331474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bradykinin-mediated metabolic effects in isolated perfused rat hearts.
    Schoelkens BA; Linz W
    Agents Actions Suppl; 1992; 38 ( Pt 2)():36-42. PubMed ID: 1462841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Attenuation of myocardial stunning by the ACE inhibitor ramiprilat through a signal cascade of bradykinin and prostaglandins but not nitric oxide.
    Ehring T; Baumgart D; Krajcar M; Hümmelgen M; Kompa S; Heusch G
    Circulation; 1994 Sep; 90(3):1368-85. PubMed ID: 8087948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reperfusion injury in the endotoxin-treated rat heart: reevaluation of the role of nitric oxide.
    Yang BC; Chen LY; Saldeen TG; Mehta JL
    Br J Pharmacol; 1997 Jan; 120(2):305-11. PubMed ID: 9117124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of angiotensin-converting enzyme reduces rat liver reperfusion injury via bradykinin-2-receptor.
    Freise H; Palmes D; Spiegel HU
    J Surg Res; 2006 Aug; 134(2):231-7. PubMed ID: 16513137
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.